(Q77.6) Chondroectodermal dysplasia

More details coming soon

Icon
37 652 in individuals diagnosis chondroectodermal dysplasia confirmed
Icon
2 760 deaths with diagnosis chondroectodermal dysplasia
Icon
7% mortality rate associated with the disease chondroectodermal dysplasia

Diagnosis chondroectodermal dysplasia is diagnosed Women are 21.26% more likely than Men

14 824

Men receive the diagnosis chondroectodermal dysplasia

1 527 (10.3 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
22 828

Women receive the diagnosis chondroectodermal dysplasia

1 233 (5.4 %)

Died from this diagnosis.

Risk Group for the Disease chondroectodermal dysplasia - Men aged 5-9 and Women aged 10-14

Icon
In Men diagnosis is most often set at age 0-19, 25-34
Icon
Less common in men the disease occurs at Age 20-24, 35-95+Less common in women the disease occurs at Age 40-44, 55-59, 70-79, 85-95+
Icon
In Women diagnosis is most often set at age 0-39, 45-54, 60-69, 80-84

Disease Features chondroectodermal dysplasia

Icon
Absence or low individual and public risk
Icon

Chondroectodermal dysplasia - what does this mean

Chondroectodermal dysplasia is an inherited disorder caused by a mutation in the eftud2 gene. it affects the development of bones, cartilage, and connective tissue, leading to short stature, abnormal growth of the ribs, and abnormalities of the fingers and toes. it is also associated with hearing loss, pulmonary valve stenosis, and other heart problems.

What happens during the disease - chondroectodermal dysplasia

Chondroectodermal dysplasia is a rare genetic disorder caused by a mutation in the eftud2 gene. this mutation affects the development of cartilage and bone, leading to skeletal abnormalities such as short stature, joint contractures, and malformations of the rib cage and vertebrae. it is also associated with abnormalities of the heart, eyes, and urinary system. the exact mechanism of the disease is still unknown, but it is thought to be caused by a defect in the synthesis of collagen and other proteins required for the development of cartilage and bone.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete physical examination
  • X-ray imaging to detect skeletal abnormalities
  • CT scan to assess for any soft tissue abnormalities
  • Ultrasound imaging to identify any internal organ abnormalities
  • Genetic testing to confirm the diagnosis
  • Blood tests to rule out other possible causes

Treatment and Medical Assistance

Main goal of the treatment: To improve the physical and functional abilities of the patient with Chondroectodermal dysplasia.
  • Physical therapy
  • Occupational therapy
  • Speech therapy
  • Surgery to correct skeletal abnormalities
  • Medications to control pain
  • Assistive devices and orthotics
  • Counseling and support
Icon
28 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Chondroectodermal dysplasia - Prevention

Prevention of chondroectodermal dysplasia is primarily achieved through genetic counseling and pre-natal testing. couples who have a family history of the disorder should seek genetic counseling to understand their risk of having a child with chondroectodermal dysplasia, and if necessary, pre-natal testing can be done to determine if the fetus is affected.